Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0043226 | organelle | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HGY0
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005524 | ATP binding | 5 | 2 |
GO:0017076 | purine nucleotide binding | 4 | 2 |
GO:0030554 | adenyl nucleotide binding | 5 | 2 |
GO:0032553 | ribonucleotide binding | 3 | 2 |
GO:0032555 | purine ribonucleotide binding | 4 | 2 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 2 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 2 |
GO:0036094 | small molecule binding | 2 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043168 | anion binding | 3 | 2 |
GO:0044183 | protein folding chaperone | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0097367 | carbohydrate derivative binding | 2 | 2 |
GO:0140657 | ATP-dependent activity | 1 | 2 |
GO:0140662 | ATP-dependent protein folding chaperone | 2 | 2 |
GO:1901265 | nucleoside phosphate binding | 3 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.526 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 156 | 160 | PF00082 | 0.211 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.526 |
CLV_Separin_Metazoa | 169 | 173 | PF03568 | 0.526 |
DOC_CKS1_1 | 114 | 119 | PF01111 | 0.526 |
DOC_MAPK_gen_1 | 138 | 147 | PF00069 | 0.526 |
DOC_MAPK_gen_1 | 193 | 200 | PF00069 | 0.526 |
DOC_MAPK_HePTP_8 | 94 | 106 | PF00069 | 0.526 |
DOC_MAPK_MEF2A_6 | 97 | 106 | PF00069 | 0.526 |
DOC_PP1_RVXF_1 | 236 | 243 | PF00149 | 0.526 |
DOC_PP2B_PxIxI_1 | 101 | 107 | PF00149 | 0.526 |
DOC_USP7_MATH_2 | 117 | 123 | PF00917 | 0.526 |
DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.526 |
DOC_USP7_UBL2_3 | 93 | 97 | PF12436 | 0.526 |
DOC_WW_Pin1_4 | 113 | 118 | PF00397 | 0.526 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.526 |
LIG_14-3-3_CanoR_1 | 238 | 243 | PF00244 | 0.526 |
LIG_Clathr_ClatBox_1 | 211 | 215 | PF01394 | 0.526 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.526 |
LIG_FHA_2 | 114 | 120 | PF00498 | 0.526 |
LIG_FHA_2 | 222 | 228 | PF00498 | 0.526 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.526 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.526 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.356 |
LIG_LIR_Gen_1 | 13 | 20 | PF02991 | 0.526 |
LIG_LIR_Gen_1 | 38 | 48 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 13 | 18 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 38 | 44 | PF02991 | 0.526 |
LIG_SH2_CRK | 15 | 19 | PF00017 | 0.526 |
LIG_SH2_GRB2like | 150 | 153 | PF00017 | 0.526 |
LIG_SH2_NCK_1 | 15 | 19 | PF00017 | 0.526 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.526 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.264 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.526 |
LIG_SH3_3 | 142 | 148 | PF00018 | 0.526 |
LIG_SUMO_SIM_anti_2 | 208 | 213 | PF11976 | 0.526 |
LIG_SUMO_SIM_anti_2 | 24 | 30 | PF11976 | 0.526 |
LIG_SUMO_SIM_par_1 | 210 | 215 | PF11976 | 0.526 |
LIG_TRAF2_1 | 116 | 119 | PF00917 | 0.481 |
LIG_TYR_ITSM | 11 | 18 | PF00017 | 0.526 |
LIG_UBA3_1 | 125 | 129 | PF00899 | 0.526 |
LIG_WRC_WIRS_1 | 239 | 244 | PF05994 | 0.526 |
MOD_CK2_1 | 113 | 119 | PF00069 | 0.176 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.351 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.526 |
MOD_Cter_Amidation | 74 | 77 | PF01082 | 0.526 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.526 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.211 |
MOD_N-GLC_1 | 151 | 156 | PF02516 | 0.526 |
MOD_N-GLC_1 | 34 | 39 | PF02516 | 0.526 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.526 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.526 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.526 |
MOD_NEK2_2 | 63 | 68 | PF00069 | 0.526 |
MOD_PIKK_1 | 151 | 157 | PF00454 | 0.526 |
MOD_Plk_1 | 118 | 124 | PF00069 | 0.395 |
MOD_Plk_1 | 207 | 213 | PF00069 | 0.526 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.526 |
MOD_Plk_4 | 207 | 213 | PF00069 | 0.526 |
MOD_Plk_4 | 238 | 244 | PF00069 | 0.526 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.526 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.526 |
MOD_ProDKin_1 | 113 | 119 | PF00069 | 0.526 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.526 |
MOD_SUMO_rev_2 | 105 | 115 | PF00179 | 0.526 |
MOD_SUMO_rev_2 | 215 | 224 | PF00179 | 0.526 |
TRG_DiLeu_BaEn_1 | 194 | 199 | PF01217 | 0.526 |
TRG_DiLeu_BaEn_3 | 118 | 124 | PF01217 | 0.526 |
TRG_DiLeu_BaLyEn_6 | 46 | 51 | PF01217 | 0.526 |
TRG_DiLeu_BaLyEn_6 | 69 | 74 | PF01217 | 0.526 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.526 |
TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.526 |
TRG_NES_CRM1_1 | 118 | 130 | PF08389 | 0.526 |
TRG_Pf-PMV_PEXEL_1 | 172 | 176 | PF00026 | 0.526 |
TRG_Pf-PMV_PEXEL_1 | 49 | 53 | PF00026 | 0.351 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4II73 | Bodo saltans | 35% | 75% |
A0A0S4KFF1 | Bodo saltans | 35% | 100% |
A4HII1 | Leishmania braziliensis | 54% | 100% |
A4HII6 | Leishmania braziliensis | 52% | 100% |
C9ZR49 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9B120 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 56% | 72% |
P12077 | Leishmania major | 67% | 100% |
P22623 | Paracentrotus lividus | 73% | 66% |
P48741 | Homo sapiens | 77% | 67% |